Page last updated: 2024-08-22

angiotensin ii and Diabetic Glomerulosclerosis

angiotensin ii has been researched along with Diabetic Glomerulosclerosis in 270 studies

Research

Studies (270)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (6.67)	18.7374
1990's	23 (8.52)	18.2507
2000's	133 (49.26)	29.6817
2010's	82 (30.37)	24.3611
2020's	14 (5.19)	2.80

Authors

Authors	Studies
Azushima, K; Haruhara, K; Kato, I; Kawase, W; Kinguchi, S; Kobayashi, R; Kurotaki, D; Ohashi, K; Ohki, K; Suzuki, T; Tamura, K; Tamura, T; Tsuboi, N; Uneda, K; Wakui, H; Yamaji, T; Yamashita, A; Yokoo, T	1
Nishi, H	1
Chen, Z; Ding, G; Feng, J; Hu, J; Liang, W; Luo, Q; Luo, Z; Yang, H; Zhang, Z; Zhu, Z	1
Peng, L; Xiao, G; Zhang, C	1
Das-Earl, P; Inman, D; Ma, R; Tao, Y; Yazdizadeh Shotorbani, P	1
Chen, G; Lu, J; Ouyang, W; Shen, G	1
Cui, Y; Dong, C; Guo, Q; Liu, S	1
Abbas, AM; Badi, RM; Bashir, SO; Mohammed, ME; Morsy, MD; Osman, OM; Saeed, AM	1
Bjornstad, P; Cham, L; Cherney, DZI; Lai, V; Lovblom, LE; Lytvyn, Y; Melena, I; Orszag, A; Perkins, BA; Piani, F; Reinicke, T; Tse, J	1
Bernstein, EA; Bernstein, KE; Cao, D; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; Okwan-Duodu, D; Shen, JZY; Veiras, LC	1
Batlle, D; Soler, MJ	1
Du, WY; Gao, H; Han, SL; Lin, J; Sun, XF; Zhang, YJ	1
Bahreini, E; Nabi-Afjadi, M; Rezaei-Chianeh, Y	1
Keshawy, MM; Makary, S; Tawfik, MK	1
Nangaku, M; Ross, MJ	1
Jang, HC; Kim, KM; Kong, SH; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ; Park, KS	1
Dong, J; Guo, C; Liao, L; Mou, Y; Zhang, Y; Zhang, Z; Zhao, J; Zhou, X	1
Bjornstad, P; Boulet, G; Brent, MH; Bril, V; Cham, L; Cherney, DZ; Farooqi, MA; Keenan, HA; Lai, V; Lovblom, LE; Lovshin, JA; Lytvyn, Y; Orszag, A; Paul, N; Perkins, BA; Scarr, D; Tse, J; Weisman, A	1
Aziz, NM; El-Tahawy, NF; Elbassuoni, EA	1
Ford Versypt, AN; Higgins, MA; Pilvankar, MR	1
Anguiano, L; Clotet-Freixas, S; Gimeno, J; Konvalinka, A; Palau, V; Pascual, J; Riera, M; Soler, MJ	1
Bernstein, EA; Bernstein, KE; Cao, DY; Eriguchi, M; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; McDonough, AA; Toblli, JE; Veiras, LC	1
Nemoto, W	1
Ding, W; Gan, L; Gao, L; He, H; Li, X; Li, Y; Liu, J; Ou, S; Wang, M; Wu, W	1
Chen, B; Cheng, YL; Su, SS; Sun, WX; Wang, WN; Wu, H; Xu, ZG; Zhang, YY	1
Dou, DY; Lyu, MJ; Ma, YH; Xiong, L	1
Abdo, M; Hassan, WA; Makary, S; Tawfik, MK	1
Boim, MA; Borges, FT; da Silva Novaes, A; Dias, MVS; Maquigussa, E; Varela, VA	1
Cha, SK; Chung, CH; Kang, JS; Kim, JH; Lee, ES; Lee, EY; Lee, JH; Lee, SJ; Son, SS	1
Asanuma, K; Fukami, K; Kaida, Y; Kaifu, K; Matsui, T; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S	1
Miao, J; Wang, S; Zhang, W; Zhang, Y	1
Benigni, A; Buelli, S; Gagliardini, E; Longaretti, L; Macconi, D; Morigi, M; Perico, L; Perico, N; Remuzzi, G; Rizzo, P; Tomasoni, S; Zoja, C	1
Chen, CX; Dong, Z	1
Batlle, D; Burns, KD; Garcia-Halpin, L; Maier, C; Sowers, K; Wysocki, J; Ye, M	1
Chen, JR; Wu, LY; Yang, HY; Yeh, WJ	1
Abdul, A; Deb, DK; Heilig, CW; James, LR; Nahman, NS; Riaz, H; Salameh, J	1
Chappell, MC	1
Ma, C; Wang, SS; Wang, YX; Zhang, W; Zhang, YS	1
Guo, Q; Sagar, SK; Yi, R; Zhang, C	1
Crisóstomo, J; Matafome, P; Pereira, P; Rodrigues, L; Santos-Silva, D; Seiça, R; Sena, C	1
Carter, A; He, Y; Hébert, RL; Kennedy, CRJ; Nasrallah, R; Thibodeau, JF; Touyz, R	1
Liu, BC; Liu, J; Lv, LL; Ma, KL; Ni, J; Ruan, XZ; Wang, CX; Wu, Y; Zhang, Y	1
Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y	1
Li, CM; Li, M; Lou, TQ; Luo, PL; Peng, H; Xing, YF; Ye, ZC	1
Baltissen, MP; Berden, JH; Hoenderop, JG; Nijenhuis, T; Sonneveld, R; van der Vlag, J; Verkaart, SA; Wetzels, JF	1
Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y	1
Duan, XC; Fang, ZH; Gao, JR; Wang, YZ; Wu, J; Xia, LZ; Yao, XM	1
Márquez, E; Pascual, J; Riera, M; Soler, MJ	1
Cinar, R; Earley, BJ; Godlewski, G; Jourdan, T; Ju, C; Kunos, G; Liu, J; Liu, Z; Pacher, P; Rosenberg, AZ; Szanda, G; Tam, J	1
Heeba, GH; Mahmoud, ME; Morsy, MA	1
Chen, Q; Chen, Y; Lv, J; Shao, Y; Shi, J	1
Chang, YH; Chen, JW; Chien, S; Chu, PH; Huang, PH; Li, SY; Lin, CC; Lin, SJ; Lin, TP; Schmid-Schönbein, GW; Tarng, DC; Yang, AH; Yang, MH; Yang, WC	1
Chen, F; Chen, X; Deng, Y; Ding, D; Du, Y; Hu, X; Liao, Y; Qiu, Z; Wang, L; Wang, M; Wang, S; Wu, H; Yan, S; Yang, S; Yu, X; Zhang, H; Zhou, Y; Zhou, Z	1
Ilatovskaya, DV; Levchenko, V; Lowing, A; Palygin, O; Shuyskiy, LS; Staruschenko, A	1
Cheng, YL; Wang, WN; Xu, HZ; Xu, ZG; Zhang, YY	1
Ding, F; Ding, J; Li, B; Li, X; Zhang, X	1
Ji, ZZ; Xu, YC	1
Chen, J; Chen, M; Gu, J; He, L; Hu, H; Jing, Y; Li, L; Mei, C; Mei, S; Qi, N; Song, S; Sun, L; Wu, M; Wüthrich, RP; Yang, M	1
Re, RN	1
Batlle, D; David, NV; Fogo, A; Kanwar, Y; Khattab, AM; Martin, A; Osborn, M; Wysocki, J; Ye, M	1
Gómez, O; Molina-Holgado, E; Uceda, ER; Vera, ME; Vieitez, P	1
Feliers, D; Ghosh Choudhury, G; Kasinath, BS; Lee, MJ; Mariappan, MM; Sataranatarajan, K	1
Hosomi, N; Imanishi, M; Ito, S; Kiyomoto, H; Kobori, H; Konishi, Y; Meda, I; Mori, T; Morikawa, T; Nagai, Y; Nakagawa, T; Nishiyama, A; Okada, N; Okumura, M	1
Bierhaus, A; Bozorgmehr, F; Dugi, K; Hamann, A; Humpert, PM; Ibrahim, Y; Kientsch-Engels, R; Kukudov, G; Morcos, M; Nawroth, PP; Oikomonou, D; Pfisterer, F; Rudofsky, G; Sayed, AA; Schlotterer, A; Schneider, J; Schwenger, V; van der Woude, F; Yard, B; Zeier, M	1
Cha, DR; Han, JY; Han, KH; Han, SY; Kang, YS; Kim, BK; Kim, HK; Ko, GJ; Lee, MH; Park, YG; Song, HK	1
Abadir, PM; Abdel-Rahman, EM; Siragy, HM	1
Degrell, P; Fekete, A; Prokai, A; Ronai, K; Rosta, K; Rusai, K; Ruzicska, E; Somogyi, A; Szabo, AJ; Toth, M; Tulassay, T; Vegh, E; Ver, A; Wagner, L	1
Gul, R; Jang, KY; Kim, SY; Kim, UH; Park, KH	1
Gao, L; Mann, GE	1
Jung, KH; Kim, SK; Lee, BC	1
Hayashi, T; Takai, S; Yamashita, C	1
Arbeeny, C; Chen, Y; Deb, DK; Kong, J; Li, G; Li, YC; Ning, G; Sabbagh, Y; Strugnell, S; Wang, Y; Zhang, Y; Zhang, Z	1
Ravid, M	1
He, M; Lu, LM; Shao, Y; Wang, XF; Xue, H; Yao, T; Yu, C; Zhang, L; Zhou, L	1
Burt, D; Camussi, G; Gruden, G; Miceli, I; Perin, PC; Tarabra, E	1
Lorenz, JN	1
Basu, R; Chow, FL; Herzenberg, AM; Janzek, E; Kassiri, Z; Liu, GC; Loibner, H; Oudit, GY; Penninger, JM; Scholey, JW; Schuster, M; Zhong, J; Zhou, J	1
Savvatis, K; Schultheiss, HP; Tschöpe, C; Westermann, D	1
Bramlage, P; Schindler, C	1
Collins, AR; Hsueh, WA; Kim, J; Liu, J; Nguyen, L; Nicholas, SB; Ren, Y	1
Iwamoto, Y; Maekawa, Y; Ohishi, M; Ohnishi, M; Rakugi, H; Shiota, A; Takeda, M; Tatara, Y; Yamamoto, K	1
Bosch, RJ; Izquierdo, A; López-Luna, P; Ortega, A; Romero, M	1
Macconi, D	1
Bilan, VP; Jackson, EK; Tofovic, DS	1
Li, XY; Long, HB; Niu, HX; Wei, LB; Xu, ZZ; Zhang, H; Zhong, J	1
Appelhoff, RJ; Endre, ZH; Findon, G; Hill, JV	1
Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Sasaki, S; Takayanagi, R; Zheng, J	1
Kino, T; Matsuzawa, Y; Nishikawa, T; Omura, M; Saito, J; Suematsu, S	1
Glassock, RJ	1
Li, Y; Visavadiya, NP; Wang, S	1
Gao, Y; Liu, XH; Yu, DQ	1
Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A	1
Campbell, KN; Mundel, P; Raij, L	1
Lee, HS	1
Huang, LY; Su, S; Wang, TC; Yang, MC; Yeh, HL	1
Ding, H; Guo, Y; Huang, Q; Xie, W; Yan, H; Zeng, H	1
Aoki, T; Gohda, T; Hagiwara, S; Ihm, CG; Ishikawa, Y; Jeong, KH; Lee, SH; Lee, TW; Lim, SJ; Moon, JY; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Yamazaki, T	1
Aizawa, Y; Giridharan, VV; Harima, M; Kodama, M; Lakshmanan, AP; Sari, FR; Soetikno, V; Thandavarayan, RA; Watanabe, K	1
Kamgar, M; Nobakht, N; Rastogi, A; Schrier, RW	1
Cooper, ME; Herman-Edelstein, M; Kantharidis, P; Saleem, M; Thallas-Bonke, V; Thomas, MC	1
Abboud, HE; Ding, M; Ding, Y; Gorin, Y; Graham, S; Lee, DY; Ma, R; Shi, H	1
Franke, S; Fraune, C; Krebs, C; Rüster, C; Schmidthaupt, R; Wenzel, U; Wolf, G	1
Benito-Martin, A; Egido, J; Mathieson, PW; Mezzano, S; Ortiz, A; Ruiz-Ortega, M; Saleem, MA; Sanchez-Lopez, E; Sanchez-Niño, MD; Sanz, AB	1
Abe, H; Doi, T; Matsubara, T; Tominaga, T	1
Batlle, D; Ranganath, K; Soler, MJ; Wysocki, J	1
Attia, J; Ingsathit, A; Lertrattananon, D; Ngarmukos, C; Thakkinstian, A; Vejakama, P	1
Ishibashi, Y; Maeda, S; Matsui, T; Nakashima, S; Nishino, Y; Ojima, A; Yamagishi, S	1
Cahill, C; Geraldes, P; Hiraoka-Yamomoto, J; King, GL; Kitada, M; Li, C; Li, Q; Matsumoto, M; Mima, A; Mizutani, K; Nishikawa, S; Park, K; Rask-Madsen, C	1
Albino-Teixeira, A; Fasching, A; Morato, M; Palm, F; Patinha, D; Pinho, D	1
Mansoor, GA; Thavarajah, S	1
Chen, J; Gu, Y; Lin, F; Lin, S; Ma, J; Yang, H; Zhu, W	1
Goto, A	1
Inomata, S	1
Adler, SG; Kang, SW; Kim, YS; Lanting, L; Nadler, JL; Natarajan, R; Reddy, MA; Rossi, J; Shahed, A	1
Abboud, HE; Gorin, Y; Kasinath, BS; Rincon-Choles, H	1
Klahr, S; Morrissey, J	1
Luño, J; Ruilope, LM	1
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L	1
Dikow, R; Eberhard, R	1
Carswell, CI; Goa, KL	1
Scholey, JW	1
Hollenberg, NK; Price, DA	1
Camussi, G; Deferrari, G; Doublier, S; Lupia, E; Ruotsalainen, V; Salvidio, G; Verzola, D	1
Berl, T; Drury, PL; Esmatjes, E; Goldhaber, SZ; Hricik, D; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Parikh, CR; Pfeffer, MA; Porush, JG; Raz, I; Rouleau, JL; Vanhille, P; Wiegmann, TB; Wolfe, BM	1
How, HY; Sibai, BM	1
Blumenstein, M; Dietrich, W	1
Chudek, J; Kokot, F; Wiecek, A	1
Mogyorósi, A; Sonkodi, S	1
Chen, WY; Huang, XR; Lan, HY; Truong, LD	1
Mohanram, A; Toto, RD	1
Moskowitz, DW	1
Gilbert, RE; Kelly, DJ; Krum, H; Wilkinson-Berka, J	1
Ciccone, E; Deelman, L; Hajnoczky, G; Henning, R; Hu, T; Kurz, B; Ma, X; Madesh, M; Sharma, K; Siva, S; Wang, L; Zhu, Y	1
Fujita, T; Goto, A; Kurihara, H; Onozato, ML; Sakai, T; Tojo, A	1
Krantz, MJ	1
Amiri, F; Banes, AK; Jenkins, J; Marrero, MB; Pollock, DM; Redd, H; Shaw, S	1
Cantarovich, F; Rangoonwala, B	1
Marshall, SM	1
Berghold, A; Horvath, K; Pieber, TR; Plank, J; Siebenhofer, A; Sommer, R; Sutton, AJ	1
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU	1
Ruilope, LM; Segura, J	1
Ahn, JD; Chang, YC; Kaneda, Y; Kim, HJ; Kim, YD; Kim, YH; Kwon, HS; Lee, HJ; Lee, IK; Lee, KU; Morishita, R; Park, JY; Park, KG; Park, KK; Yoon, KH	1
Chen, YP; Cheng, H; Ding, SS; Dong, HR; Qiu, CB; Tian, XF	1
Batlle, D; LaPointe, MS; Naaz, P; Salabat, MR; Wysocki, J; Ye, M	1
Croom, KF; Curran, MP; Goa, KL; Perry, CM	1
Azizi, M; Ménard, J	1
Awad, AS; Carey, RM; Siragy, HM; Webb, RL	1
Cao, Z; Cooper, ME; Forbes, JM; Jerums, G; Lee, FT; Long, DM; Panagiotopoulos, S	1
Hayashi, M; Ichihara, A; Inagami, T; Ishida, Y; Kaneshiro, Y; Koura, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Okada, H; Saruta, T; Suzuki, F; Tada, Y; Uddin, MN	1
Gómez-Fernández, P	1
De Vriese, AS; Flyvbjerg, A; Schrijvers, BF	1
Wolf, G	2
Baik, SH; Cha, DR; Choi, DS; Choi, KM; Han, KH; Han, SY; Ji, YH; Kang, YS; Kim, NH; Kim, SG; Lee, KW; Oh, JH; Seo, JA	1
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T	1
Gaciong, Z	1
Bertsche, T; Schulz, M	1
Adler, SG; Cheon Park, H; Ha, SK; Han, DS; Kang, SW; Natarajan, R; Ryu, DR; Xu, ZG; Yoo, TH	1
Leehey, DJ; Singh, AK; Singh, R	1
Isreb, MA; Leehey, DJ; Marcic, S; Singh, AK; Singh, R	1
Raij, L	1
Battegay, E; Zeller, A	1
Dong, J; Liu, X; Lv, Y; Niu, X	1
Andersen, S	1
Boner, G; Brenner, BM; Cooper, ME; Crow, RS; de Zeeuw, D; Dickson, T; Kowey, PR; McCarroll, K; Parving, HH; Shahinfar, S	1
Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB	1
Boasquevisque, EM; de Lourdes Rodrigues, M; Francischetti, EA; Genelhu, V; Ismerim, VL; Matos, JP	1
Hashimoto, Y; Kon, Y; Konno, A; Tamura, J	1
Chaturvedi, N; Deinum, J	1
Hashimoto, N; Saito, Y; Seki, N; Suzuki, Y; Yagui, K	1
Banes-Berceli, AK; Brands, M; Caldwell, RW; Eaton, DC; Fulton, D; Ma, G; Marrero, MB; Shaw, S; Stern, DM	1
Matsumoto, M; Suzuki, S; Tahara, T; Taniguchi, K; Yabuki, A	1
Banes-Berceli, AK; Eaton, DC; Marrero, MB; Stern, DM	1
Brezniceanu, ML; Chan, JS; Chen, R; Fantus, IG; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Whiteside, CI; Zhang, SL	1
Doggrell, SA	1
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M	1
Cha, DR; Han, JY; Han, KH; Han, SY; Jee, YH; Kang, YS; Kim, HK; Kim, YS	1
Cao, W; Knapp, RR; Lau, K; Ma, JX; Mott, R; Wang, JJ; Zhang, SX	1
Hayashi, M; Ichihara, A; Inagami, T; Kaneshiro, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Sakoda, M; Sugaya, T; Suzuki, F; Takemitsu, T	1
Abe, H; Arai, H; Doi, T; Fukatsu, A; Iehara, N; Kanamori, H; Kita, T; Matsubara, T; Mima, A; Nagai, K; Sumi, E; Takahashi, T	1
Gavras, H; Ribeiro, AB	1
Alvarez, MJ; Arribas, I; Bosch, RJ; Esbrit, P; Guitiérrez-Tarrés, MA; Izquierdo, A; López-Luna, P; Ortega, A; Romero, M	1
Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M	1
Barit, D; Cooper, ME; Giunti, S	1
Chan, CM; Lau, YK; Wong, KS; Woo, KT	1
Prabhakar, S; Rosario, RF	1
Burns, KD	2
Kashihara, N; Maeshima, Y; Makino, H; Maruyama, K; Okamoto, K; Okazaki, Y; Satoh, M; Sugaya, T; Sugiyama, H; Uchida, HA; Yamasaki, Y	1
Brenner, BM; Cooper, ME; de Zeeuw, D; Eijkelkamp, WB; Gleim, GW; Keane, WF; Parving, HH; Remuzzi, G; Shahinfar, S; Weir, MR; Zhang, Z	1
Casarini, DE; Irigoyen, MC; Ronchi, FA	1
Batlle, D; Kanwar, Y; Lloveras, J; Soler, MJ; Wysocki, J; Ye, M	1
Han, HJ; Lee, YJ	1
Casarini, DE; Fiorino, P; Irigoyen, MC; Lagranha, CJ; Schaan, BD	1
Anderson, S; Komers, R; Lindsley, JN; Oyama, TT; Schutzer, W; Xue, H	1
Lai, EY; Nordquist, L; Patzak, A; Persson, AE; Sjöquist, M	1
Durvasula, RV; Shankland, SJ	1
Camussi, G; Gruden, G; Perin, PC	1
Fulton, D; Marrero, MB; Stepp, D; Stern, DM	1
Wolf, G; Ziyadeh, FN	2
Adler, SG; Kato, M; Lanting, L; Li, SL; Natarajan, R; Reddy, MA; Shanmugam, N; Wang, M; Xu, ZG; Yuan, H	1
Fenton-Lee, CA; Polhill, TS; Pollock, CA; Poronnik, P; Saad, S; Stevens, VA	1
Feliers, D; Lee, MJ; Mariappan, MM; Sataranatarajan, K	1
Goncharov, NP; Il'in, AV; Katsaia, GV; Koshel', LV; Malysheva, NM; Nikankina, LV; Shamkhlova, MSh; Shestakova, MV; Trubitsyna, NP	1
Bradley, TJ; Cherney, DZ; Dekker, MG; Hébert, RL; Miller, JA; Nasrallah, R; Scholey, JW; Slorach, C; Sochett, EB	1
Kang, JJ; Meer, EJ; Peti-Peterdi, J; Sipos, A; Toma, I; Vargas, SL	1
Jackson, EK; Mi, Z	1
Koitka, A; Tikellis, C	1
Arnoni, CP; Boim, MA; Casarini, DE; Cristovam, PC; de Andrade, MC; Pereira, LG; Schor, N	1
Drury, PL	1
Aurell, M; Björck, S; Delin, K; Herlitz, H; Larsson, O	1
Maezawa, H; Odakura, T; Sugiyama, H; Uchimura, I	1
de Jong, PE; de Zeeuw, D; Gansevoort, RT	1
Christensen, P; Feldt-Rasmussen, B; Jensen, T; Nørgaard, K	1
Charlesworth, JA; Duggan, K; Macdonald, GJ; Makarious, M	1
Eaton, DC; Ling, BN; Ma, H; Matsunaga, H	1
Bender, R; Berger, M; Dworschak, A; Mühlhauser, I; Prange, K; Sawicki, PT; Schaden, W	1
Fleming, JT; Inman, SR; Porter, JP	1
Epstein, M; Forster, HG; Hohman, TC; ter Wee, PM	1
Allen, TJ; Casley, D; Cooper, ME; Jerums, G; Waldron, MJ	1
Ferreira, AT; Hadad, SJ; Neri, R; Oshiro, ME; Schor, N	1
Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E	1
Krämer, BK; Ritz, E; Wieçek, A	1
Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S	1
Anderson, S; Kennefick, TM	1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S	1
Anderson, S	1
McCarty, MF	1
Agarwal, M; Nicholls, MG; Richards, AM	1
Brands, MW; Granger, JP	1
Williams, B	1
Hollenberg, NK; Laffel, LM; Lansang, MC; Osei, SY; Price, DA	1
Heidland, A; Teschner, M	1
Alavi, N; Leehey, DJ; Singh, AK; Singh, R	1
Burns, KD; Imig, JD; Kumar, D; Levine, DZ; Navar, LG; Wehbi, G; Zimpelmann, J	1
Abe, A; Hosoya, T; Imasawa, T; Kuriyama, S; Tomonari, H	1
El Khyat, Z; El Sayed, A; Ibrahim, S; Nicola, W; Salah, A; Sidhom, G	1
Hauser, AC; Hörl, WH	1
Mogensen, CE	1
Brenner, BM; Cooper, ME; de Zeeuw, D; Keane, WF; Mitch, WE; Parving, HH; Remuzzi, G; Shahinfar, S; Snapinn, SM; Zhang, Z	1
Andersen, S; Arner, P; Brøchner-Mortensen, J; Gomis, R; Lehnert, H; Parving, HH	1
Atkins, RC; Cooper, ME; Gilbert, RE; Jerums, G	1
Beevers, DG; Lip, GY	1
Okada, M; Takemura, T; Yanagida, H; Yoshioka, K	1
Attvall, S; Nilsson, P	1
Arner, P	1
Amiri, F; Eaton, DC; Marrero, MB; Shaw, S; Tang, J; Waller, JL; Wang, X	1
Cheung, BM	1
Draganov, B; Holdaas, H; Høieggen, A; Jenssen, T; Os, I; Stenehjem, A	1
Kokot, F	1
Christlieb, AR	2
Ikeda, T	1
Bosch, RJ; Fine, LG; Woolf, AS	1
Kikkawa, R; Shigeta, Y	1
Amiel, C; Blanchet, F; Friedlander, G; Nitenberg, A	1
Aynedjian, HS; Bank, N; Lahorra, MA; Schlondorff, D	1
Giese, J; Hommel, E; Mathiesen, ER; Nielsen, MD; Parving, HH; Schütten, HJ	1
Thompson, J; Whiteside, CI	1
Kaysen, GA; Krolewski, AS; Meyer, TW; Noth, RH; Schambelan, M	1
Yaginuma, K	1
Damkjaer Nielsen, M; Edsberg, B; Giese, J; Hommel, E; Mathiesen, E; Parving, HH	1
Ahmad, S	1
Bent-Hansen, L; Christensen, NJ; Deckert, T; Feldt-Rasmussen, B; Giese, J; Mathiesen, ER; Nielsen, MD	1
Hermann, J; Murphy, R; Patz, A; Walker, WG	1
Berkmen, R	1
Yoshida, H	1

Reviews

87 review(s) available for angiotensin ii and Diabetic Glomerulosclerosis

Article	Year
12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy. European journal of pharmacology, 2020, Jul-15, Volume: 879 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Albuminuria; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Diabetic Nephropathies; Epigenesis, Genetic; Epoprostenol; Humans	2020
Novel roles of the renal angiotensin-converting enzyme. Molecular and cellular endocrinology, 2021, 06-01, Volume: 529 Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance	2021
Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review. The review of diabetic studies : RDS, 2021,Spring, Volume: 17, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Renin; Renin-Angiotensin System	2021
[Behavioral and Molecular Pharmacological Study of the Role of Angiotensin II in Spinal Pain Transmission]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:10 Topics: Angiotensin II; Animals; Brain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pain; Pain Perception; Peptidyl-Dipeptidase A; Phosphorylation; Spinal Cord; Synaptic Transmission; Up-Regulation	2018
GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy. American journal of nephrology, 2013, Volume: 38, Issue:1 Topics: Angiotensin II; Animals; Connective Tissue Growth Factor; Diabetic Nephropathies; Glucose; Glucose Transporter Type 1; Humans; Hyperglycemia; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2013
Renin-angiotensin system within the diabetic podocyte. American journal of physiology. Renal physiology, 2015, Jan-01, Volume: 308, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Humans; Insulin; Podocytes; Renin-Angiotensin System	2015
A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders. The Medical clinics of North America, 2017, Volume: 101, Issue:1 Topics: Angiotensin II; Cardio-Renal Syndrome; Diabetic Nephropathies; Disease Progression; Humans; Intercellular Signaling Peptides and Proteins; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction	2017
Novel mechanisms of protein synthesis in diabetic nephropathy--role of mRNA translation. Reviews in endocrine & metabolic disorders, 2008, Volume: 9, Issue:4 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Diabetic Nephropathies; Eukaryotic Initiation Factors; Extracellular Matrix; Humans; Hypertrophy; Kidney; MicroRNAs; Models, Biological; Peptide Chain Elongation, Translational; Protein Biosynthesis; RNA, Messenger; Signal Transduction	2008
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovascular research, 2009, Apr-01, Volume: 82, Issue:1 Topics: Angiotensin II; Animals; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Activation; Glycation End Products, Advanced; Humans; Insulin Resistance; Mitochondria; NADPH Oxidases; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Protein Kinase C; Reactive Oxygen Species; Signal Transduction	2009
Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus. Current vascular pharmacology, 2010, Volume: 8, Issue:2 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Oxidative Stress; Renin-Angiotensin System	2010
Dual blockade of the renin-angiotensin system in diabetic nephropathy. Diabetes care, 2009, Volume: 32 Suppl 2 Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Meta-Analysis as Topic; Renin-Angiotensin System	2009
Rational of the use of aliskiren in hypertension and beyond. Minerva cardioangiologica, 2009, Volume: 57, Issue:6 Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Europe; Fumarates; Germany; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Japan; Prevalence; Prorenin Receptor; Protein Precursors; Randomized Controlled Trials as Topic; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Risk Factors; Tetrazoles; Time Factors; World Health Organization	2009
Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartan. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:4 Topics: Administration, Oral; Angiotensin II; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Blood Pressure; Diabetic Nephropathies; Health Care Costs; Humans; Hypertension; Irbesartan; Losartan; Tetrazoles; Treatment Outcome	2010
Targeting the renin angiotensin system for remission/regression of chronic kidney disease. Histology and histopathology, 2010, Volume: 25, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Models, Biological; Proteinuria; Remission Induction; Renal Insufficiency, Chronic; Renin-Angiotensin System	2010
Uremia (end-stage renal disease): how cost-effective are preventive strategies? Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2010, Volume: 20, Issue:5 Suppl Topics: Angiotensin II; Antihypertensive Agents; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Mass Screening; Proteinuria	2010
Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Current diabetes reviews, 2011, Volume: 7, Issue:1 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Humans; Models, Biological; Oxidative Stress; Podocytes	2011
Pathogenic role of TGF-β in the progression of podocyte diseases. Histology and histopathology, 2011, Volume: 26, Issue:1 Topics: Angiotensin II; Animals; Biomechanical Phenomena; Connective Tissue Growth Factor; Denys-Drash Syndrome; Diabetic Nephropathies; Glomerular Basement Membrane; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Kidney Diseases; Models, Biological; Paracrine Communication; Podocytes; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2011
Limitations of angiotensin inhibition. Nature reviews. Nephrology, 2011, Volume: 7, Issue:6 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Humans; Hypertension, Renal; Renin; Renin-Angiotensin System	2011
[BMP4-Smad1 signaling pathway in pathogenesis of diabetic nephropathy]. Nihon Jinzo Gakkai shi, 2011, Volume: 53, Issue:7 Topics: Albuminuria; Angiotensin II; Animals; Biomarkers; Bone Morphogenetic Protein 4; Diabetic Nephropathies; Humans; Signal Transduction; Smad1 Protein	2011
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney international, 2012, Volume: 81, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Humans; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins	2012
Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia, 2012, Volume: 55, Issue:3 Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Failure, Chronic; Middle Aged; Randomized Controlled Trials as Topic; Renin-Angiotensin System	2012
Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects? Current hypertension reports, 2002, Volume: 4, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Cardiovascular System; Diabetes Mellitus; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	2002
[Erythropoietin-depletion induced anemia in early or advanced diabetic nephropathy]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 8 Topics: Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Autonomic Nervous System Diseases; Diabetic Nephropathies; Diabetic Neuropathies; Erythropoietin; Humans; Recombinant Proteins	2002
Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy. Kidney international. Supplement, 2002, Issue:82 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Kidney; Oxidative Stress; Renin-Angiotensin System; Signal Transduction	2002
Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney international. Supplement, 2002, Issue:82 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Disease Progression; Humans; Kidney Failure, Chronic; Nephritis, Interstitial; Plasma Kallikrein; Renin-Angiotensin System	2002
Angiotensin blockade in type 2 diabetic renal disease. Kidney international. Supplement, 2002, Issue:82 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Evidence-Based Medicine; Humans; Renin-Angiotensin System; Treatment Outcome	2002
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil	2002
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes. Annals of medicine, 2002, Volume: 34, Issue:7-8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension, Renal; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles	2002
Losartan in diabetic nephropathy. Drugs, 2003, Volume: 63, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Losartan; Receptor, Angiotensin, Type 1	2003
Angiotensin II and the glomerulus: focus on diabetic kidney disease. Current hypertension reports, 2003, Volume: 5, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Humans; Kidney Glomerulus; Renin-Angiotensin System	2003
Angiotensin receptor blockers in diabetic nephropathy. Current diabetes reports, 2001, Volume: 1, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Humans; Irbesartan; Renin-Angiotensin System; Tetrazoles	2001
Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2002, Volume: 12, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Embryonic and Fetal Development; Female; Humans; Preconception Care; Pregnancy; Women's Health	2002
Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Prognosis; Receptors, Angiotensin; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome	2003
Treatment of diabetic nephropathy with angiotensin II blockers. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Severity of Illness Index; Treatment Outcome	2003
Outcome studies in diabetic nephropathy. Seminars in nephrology, 2003, Volume: 23, Issue:3 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles	2003
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetes. Diabetes technology & therapeutics, 2003, Volume: 5, Issue:2 Topics: Aging; Angiotensin II; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Heart Diseases; Humans; Insulin Resistance; Mechanoreceptors; Peptidyl-Dipeptidase A	2003
The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. Diabetic medicine : a journal of the British Diabetic Association, 2003, Volume: 20, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Growth Substances; Humans; Renin-Angiotensin System	2003
Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease. International journal of clinical practice, 2003, Volume: 57, Issue:9 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Predictive Value of Tests; Renin-Angiotensin System; Risk Factors	2003
Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials. Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Humans; Kidney Failure, Chronic; Morbidity; Randomized Controlled Trials as Topic	2004
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clinical therapeutics, 2003, Volume: 25, Issue:12 Topics: Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Proteinuria; Tetrazoles	2003
Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs, 2004, Volume: 64, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Randomized Controlled Trials as Topic; Tetrazoles	2004
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation, 2004, Jun-01, Volume: 109, Issue:21 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Diabetic Nephropathies; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proteinuria; Rats; Renin-Angiotensin System; Ventricular Dysfunction, Left	2004
[Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy]. Revista clinica espanola, 2004, Volume: 204, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Artery Disease; Diabetic Nephropathies; Humans; Hypertension; Renin	2004
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine reviews, 2004, Volume: 25, Issue:6 Topics: Aldehyde Reductase; Angiotensin II; Animals; Cytokines; Diabetic Nephropathies; Diglycerides; Endothelins; Glycation End Products, Advanced; Growth Substances; Hemodynamics; Humans; Hyperglycemia; Nitric Oxide; Protein Kinases	2004
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. European journal of clinical investigation, 2004, Volume: 34, Issue:12 Topics: Angiotensin II; Diabetic Nephropathies; Glycation End Products, Advanced; Growth Substances; Hemodynamics; Humans; Oxidative Stress	2004
[New therapeutic options in renal diseases--hypotensive therapy]. Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 112 Spec No Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension, Renal; Kidney Failure, Chronic; Risk Factors	2004
[Angiotensin receptor antagonists. A clinical-pharmacologic overview]. Medizinische Monatsschrift fur Pharmazeuten, 2005, Volume: 28, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Diabetic Nephropathies; Humans; Kidney Diseases; Migraine Disorders; Myocardial Infarction	2005
The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Nephropathies; Glucose; Hemodynamics; Homeostasis; Humans; Hypertension; Kidney Diseases; Nitric Oxide; Renin-Angiotensin System	2005
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Praxis, 2005, Apr-13, Volume: 94, Issue:15 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors	2005
Angiotensin II receptor blockade in diabetic nephropathy. Danish medical bulletin, 2004, Volume: 51, Issue:3 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetic Nephropathies; Humans; Kidney; Kidney Glomerulus; Receptors, Angiotensin; Renin-Angiotensin System	2004
[The renin-angiotensin-aldosterone system -- more complex as previously thought]. Medizinische Klinik (Munich, Germany : 1983), 2005, Aug-15, Volume: 100, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases	2005
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2006
The Renin-Angiotensin system and vascular disease in diabetes. Seminars in vascular medicine, 2002, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Renin-Angiotensin System	2002
Role of the JAK/STAT signaling pathway in diabetic nephropathy. American journal of physiology. Renal physiology, 2006, Volume: 290, Issue:4 Topics: Angiotensin II; Diabetic Nephropathies; Glucose; Humans; Kidney Glomerulus; Protein-Tyrosine Kinases; Signal Transduction; STAT Transcription Factors	2006
Bradykinin B2 receptors as a target in diabetic nephropathy. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Heterocyclic Compounds, 3-Ring; Humans; Molecular Conformation; Prodrugs; Protease Inhibitors; Receptor, Bradykinin B2	2006
Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular System; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney; Losartan; Proteinuria; Tetrazoles	2006
Diabetic nephropathy: from mechanisms to rational therapies. Minerva medica, 2006, Volume: 97, Issue:3 Topics: Angiotensin II; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Glycation End Products, Advanced; Humans; Hypertension; Protein Kinase C; Urotensins	2006
Lipids and diabetic nephropathy. Current diabetes reports, 2006, Volume: 6, Issue:6 Topics: Angiotensin II; Animals; Apolipoproteins E; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Polymorphism, Genetic; Safety	2006
The emerging role of angiotensin-converting enzyme-2 in the kidney. Current opinion in nephrology and hypertension, 2007, Volume: 16, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetic Nephropathies; Hypertension; Kidney; Kidney Tubules, Proximal; Male; Mice; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2007
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells. Kidney international. Supplement, 2007, Issue:106 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dogs; Epidermal Growth Factor; ErbB Receptors; Glucose; Humans; Hyperglycemia; Kidney Tubules, Proximal; Mice; Rabbits; Rats; Sodium-Glucose Transport Proteins	2007
[Molecular bases of diabetic nephropathy]. Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:6 Topics: Angiotensin II; Cell Proliferation; Diabetic Nephropathies; Endothelium-Dependent Relaxing Factors; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycation End Products, Advanced; Humans; Hyperglycemia; Nitric Oxide; Oxidative Stress; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta1; Vasoconstrictor Agents	2007
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Current diabetes reviews, 2005, Volume: 1, Issue:1 Topics: Angiotensin II; Connective Tissue Growth Factor; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycosylation; Hexosamines; Humans; Hyperglycemia; Immediate-Early Proteins; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Nitric Oxide; Podocytes; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A	2005
Angiotensin II-induced signaling pathways in diabetes. Current diabetes reviews, 2005, Volume: 1, Issue:2 Topics: Angiotensin II; Cell Division; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Hyperglycemia; Muscle, Smooth, Vascular; Reactive Oxygen Species; Signal Transduction	2005
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Current diabetes reviews, 2008, Volume: 4, Issue:1 Topics: Angiotensin II; Diabetic Nephropathies; Endothelial Cells; Endothelium, Vascular; Humans; Kidney Glomerulus; Membrane Proteins; Models, Biological; Podocytes; Proteinuria; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2008
Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy. TheScientificWorldJournal, 2008, Apr-20, Volume: 8 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Humans; Models, Biological; Renin-Angiotensin System	2008
Diabetes and arterial hypertension. Diabetologia, 1983, Volume: 24, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases	1983
Role of growth factors in mesangial cell ion channel regulation. Kidney international, 1995, Volume: 48, Issue:4 Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Cyclosporine; Diabetic Nephropathies; Endothelins; Furosemide; Glomerular Mesangium; Growth Substances; Humans; Insulin; Ion Channels; Ion Transport; Models, Biological; Receptors, Angiotensin	1995
The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:1 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Down-Regulation; Glucose; Hemodynamics; Humans; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction	1997
[In what way and how intensively should blood pressure be lowered in diabetic nephropathy?]. Deutsche medizinische Wochenschrift (1946), 1997, Jun-20, Volume: 122, Issue:25-26 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Hypertension, Renovascular; Kidney Failure, Chronic	1997
Role of angiotensin II in diabetic nephropathy. Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Enalapril; Hemodynamics; Plasma Volume; Rats; Renin-Angiotensin System	1997
Role of local and systemic angiotensin in diabetic renal disease. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Diabetic Nephropathies; Humans; Renin-Angiotensin System	1997
The importance of the renin-angiotensin system in cardiovascular disease. Journal of human hypertension, 1998, Volume: 12, Issue:5 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Renin-Angiotensin System; Sensitivity and Specificity	1998
Control of renal function and blood pressure by angiotensin II: implications for diabetic glomerular injury. Mineral and electrolyte metabolism, 1998, Volume: 24, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Diabetic Nephropathies; Humans; Kidney; Kidney Glomerulus	1998
A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? Mineral and electrolyte metabolism, 1998, Volume: 24, Issue:6 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Kidney; Lymphokines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
[Lowered intrarenal protein degradation--an alternative path to glomerulosclerosis and tubulo-interstitial fibrosis]. Medizinische Klinik (Munich, Germany : 1983), 2000, Jul-15, Volume: 95, Issue:7 Topics: Angiotensin II; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Kidney; Kidney Failure, Chronic; Kidney Tubular Necrosis, Acute; Proteins; Transforming Growth Factor beta	2000
Angiotensin II and its receptors in the diabetic kidney. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Kidney Glomerulus; Mice; Peptidyl-Dipeptidase A; Proteinuria; Rats; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin	2000
Role of angiotensin II in diabetic nephropathy. Kidney international. Supplement, 2000, Volume: 77 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Endothelial Growth Factors; Endothelins; Extracellular Matrix; Glucose; Humans; Lymphokines; Nitric Oxide; Renin-Angiotensin System; Stress, Mechanical; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
[Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology]. Wiener medizinische Wochenschrift (1946), 2001, Volume: 151, Issue:7-8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Therapeutic Equivalency	2001
The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy. Journal of human hypertension, 2001, Volume: 15, Issue:12 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Middle Aged; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Tetrazoles; Treatment Outcome	2001
Blockade of the renin-angiotensin system. Hong Kong medical journal = Xianggang yi xue za zhi, 2002, Volume: 8, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Humans; Hypertension; Receptors, Angiotensin; Renin-Angiotensin System	2002
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Apr-10, Volume: 122, Issue:9 Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System	2002
[The renin-angiotensin-aldosterone system in diabetics]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1978, Jul-31, Volume: 33, Issue:31 Topics: Aldosterone; Angiotensin II; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hypertension; Kidney; Renin	1978
Growth factors in the pathogenesis of renovascular complications of diabetes mellitus. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1992, Volume: 10, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Diabetic Nephropathies; Glomerular Filtration Rate; Growth Substances; Humans; Insulin-Like Growth Factor I; Kidney Glomerulus; Platelet-Derived Growth Factor; Renin	1992
[The functional renal reserve]. Nephrologie, 1991, Volume: 12, Issue:2 Topics: Amino Acids; Angiotensin II; Diabetic Nephropathies; Dietary Proteins; Dinoprostone; Dopamine; Glomerular Filtration Rate; Glucagon; Growth Hormone; Humans; Kidney; Kidney Failure, Chronic; Renal Circulation	1991
Diabetic nephropathy: hemodynamic basis and implications for disease management. Annals of internal medicine, 1989, May-15, Volume: 110, Issue:10 Topics: Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fatty Acids, Unsaturated; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Proteinuria; Renin-Angiotensin System	1989
[Endocrinology]. Naika. Internal medicine, 1969, Volume: 23, Issue:1 Topics: 17-Ketosteroids; Adrenal Glands; Adrenal Medulla; Androgens; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Endocrine Glands; Estrogens; Growth Hormone; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Prostaglandins; Renin; Thyroxine-Binding Proteins	1969
Diabetes and hypertensive vascular disease. Mechanisms and treatment. The American journal of cardiology, 1973, Sep-20, Volume: 32, Issue:4 Topics: Alloxan; Angiotensin II; Animals; Blood Volume; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Nephrosclerosis; Rats; Renin; Sympathetic Nervous System	1973

Trials

13 trial(s) available for angiotensin ii and Diabetic Glomerulosclerosis

Article	Year
Losartan in diabetic nephropathy. Drugs, 2003, Volume: 63, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Losartan; Receptor, Angiotensin, Type 1	2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia, 2005, Volume: 48, Issue:10 Topics: Aged; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Risk Assessment; Treatment Outcome	2005
Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy. Clinical nephrology, 2005, Volume: 64, Issue:3 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome	2005
Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. Diabetes research and clinical practice, 2006, Volume: 72, Issue:2 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Humans; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Transforming Growth Factor beta	2006
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. Endocrine journal, 2006, Volume: 53, Issue:4 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta	2006
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:5 Topics: Aged; Albuminuria; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Placebos	2007
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:6 Topics: Adolescent; Adult; Angiotensin II; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Prostaglandins; Proteinuria; Pyrazoles; Renal Circulation; Sex Characteristics; Sulfonamides; Vasoconstrictor Agents; Vasodilation	2008
A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Blood pressure, 1993, Volume: 2, Issue:4 Topics: Adult; Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Isradipine; Lipoproteins; Male; Middle Aged; Potassium; Sodium	1993
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia, 1996, Volume: 39, Issue:2 Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diastole; Diet, Sodium-Restricted; Energy Intake; Epinephrine; Erythrocyte Volume; Hematocrit; Humans; Middle Aged; Norepinephrine; Patient Education as Topic; Peptidyl-Dipeptidase A; Placebos; Potassium; Renin; Renin-Angiotensin System; Sodium; Sodium, Dietary; Statistics, Nonparametric; Systole	1996
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]. Ugeskrift for laeger, 2001, Oct-01, Volume: 163, Issue:40 Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Humans; Losartan; Male; Middle Aged; Renin-Angiotensin System	2001
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes]. Ugeskrift for laeger, 2001, Oct-01, Volume: 163, Issue:40 Topics: Adult; Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Irbesartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles	2001
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British medical journal (Clinical research ed.), 1986, Aug-23, Volume: 293, Issue:6545 Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged	1986

Other Studies

171 other study(ies) available for angiotensin ii and Diabetic Glomerulosclerosis

Article	Year
Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization. Kidney international, 2022, Volume: 101, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Humans; Kidney; Macrophages; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Streptozocin	2022
Lay A TRAP for myeloid cell response in diabetic kidney disease. Kidney international, 2022, Volume: 101, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Mice; Myeloid Cells; Receptor, Angiotensin, Type 1	2022
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement. Kidney international, 2023, Volume: 103, Issue:4 Topics: Anaerobiosis; Angiotensin II; Animals; Diabetic Nephropathies; Glycolysis; Mice; Podocytes; Pyruvate Kinase; Renal Insufficiency, Chronic	2023
Astragalus polysaccharide alleviates angiotensin II-induced glomerular podocyte dysfunction by inhibiting the expression of RARRES1 and LCN2. Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:6 Topics: Albumins; Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Desmin; Diabetic Nephropathies; Lipocalin-2; Low Density Lipoprotein Receptor-Related Protein-2; Mice; Podocytes; Polysaccharides	2023
Store-operated Ca American journal of physiology. Renal physiology, 2023, 05-01, Volume: 324, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Diabetic Nephropathies; Glucose; Humans; Mice; Podocytes	2023
Ang-(1-7) attenuates podocyte injury induced by high glucose Archives of endocrinology and metabolism, 2023, Jun-19, Volume: 67, Issue:6 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Glucose; Mice; Podocytes	2023
Effect of Archives of physiology and biochemistry, 2022, Volume: 128, Issue:6 Topics: Acacia; Angiotensin II; Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-1; Glucose; Glycated Hemoglobin; Gum Arabic; Insulins; Kidney; Male; Rats; Rats, Sprague-Dawley; Senegal; Transforming Growth Factor beta1	2022
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. Journal of diabetes and its complications, 2021, Volume: 35, Issue:3 Topics: Adult; Angiotensin II; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycopeptides; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Vascular Resistance; Vasopressins	2021
Revisiting the renin-angiotensin system. Molecular and cellular endocrinology, 2021, 06-01, Volume: 529 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Chymases; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Peptide Fragments; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance	2021
Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression. Current medical science, 2021, Volume: 41, Issue:3 Topics: Angiotensin II; Animals; Apoptosis; B7-1 Antigen; Class I Phosphatidylinositol 3-Kinases; Diabetic Nephropathies; Disease Models, Animal; Glucose; Humans; Kidney; Losartan; Mice; Podocytes; Rats; Receptor, Angiotensin, Type 1; Streptozocin	2021
Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression. Molecular biology reports, 2021, Volume: 48, Issue:9 Topics: Angiopoietin-Like Protein 2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; RNA, Messenger; Streptozocin; Toll-Like Receptor 4; Treatment Outcome; Valsartan	2021
ACE2 as therapy for glomerular disease: the devil is in the detail. Kidney international, 2017, Volume: 91, Issue:6 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Humans; Kidney Glomerulus; Mice; Peptidyl-Dipeptidase A; Proteinuria	2017
Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus. Journal of diabetes and its complications, 2017, Volume: 31, Issue:10 Topics: Aged; Albuminuria; Angiotensin II; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Early Diagnosis; Endothelium, Vascular; Female; Hospitals, University; Humans; Insulin Resistance; Male; Microvessels; Middle Aged; Outpatient Clinics, Hospital; Prediabetic State; Republic of Korea; Risk Factors; Up-Regulation; Vasculitis	2017
Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells. DNA and cell biology, 2018, Volume: 37, Issue:2 Topics: Alprostadil; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Endothelin-1; Epithelial Cells; Kidney Tubules; Macrophages; Male; Nephritis, Interstitial; Rats, Wistar	2018
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes. JCI insight, 2018, 01-11, Volume: 3, Issue:1 Topics: Aged; Angiotensin II; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Renin-Angiotensin System; Vasoconstriction	2018
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2018, Volume: 43, Issue:6 Topics: Angiotensin II; Animals; Biomarkers; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Islets of Langerhans; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha	2018
Mathematical Model for Glucose Dependence of the Local Renin-Angiotensin System in Podocytes. Bulletin of mathematical biology, 2018, Volume: 80, Issue:4 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Glucose; Humans; Mathematical Concepts; Models, Biological; Podocytes; Renin-Angiotensin System; Signal Transduction	2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy. Laboratory investigation; a journal of technical methods and pathology, 2018, Volume: 98, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Feedback, Physiological; Female; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sex Characteristics	2018
The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease. Journal of the American Society of Nephrology : JASN, 2018, Volume: 29, Issue:10 Topics: Amino Acid Substitution; Angiotensin II; Animals; Catalytic Domain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Sodium Channels; Inflammation; Interleukin-1beta; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protein Domains; Renin-Angiotensin System	2018
[Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2018, Volume: 34, Issue:10 Topics: Amides; Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fumarates; Male; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction	2018
Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy. Nephron, 2019, Volume: 142, Issue:1 Topics: Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Diabetic Nephropathies; Kidney Glomerulus; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley	2019
[Effects of astragaloside-IV on the expression of inflammatory factor and proliferation of glomerular mesangial cells induced by angiotensin Ⅱ]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2018, May-08, Volume: 34, Issue:5 Topics: Angiotensin II; Blotting, Western; Cell Proliferation; Cells, Cultured; Diabetic Nephropathies; Humans; Mesangial Cells; Transforming Growth Factor beta1	2018
Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats. Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:8 Topics: Angiotensin II; Angiotensins; Animals; Collagen Type IV; Diabetic Nephropathies; Estradiol; Follicle Stimulating Hormone; Glycated Hemoglobin; Hypogonadism; Kidney; Letrozole; Luteinizing Hormone; Male; NF-kappa B; Organ Size; Oxidative Stress; Rats; Signal Transduction; Testosterone; Transforming Growth Factor beta1; Valsartan	2019
Influence of high glucose on mesangial cell-derived exosome composition, secretion and cell communication. Scientific reports, 2019, 04-18, Volume: 9, Issue:1 Topics: Angiotensin II; Cell Communication; Diabetic Nephropathies; Exosomes; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Glucose; Humans; Kidney; Mesangial Cells; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin	2019
Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Scientific reports, 2019, 05-22, Volume: 9, Issue:1 Topics: Acetylcysteine; Actin Cytoskeleton; Angiotensin II; Animals; Calcium; Cell Adhesion; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Humans; Losartan; Mice; Mice, Inbred C57BL; Microfilament Proteins; Molecular Motor Proteins; Myosin Heavy Chains; NADPH Oxidase 4; Podocytes; Rats; Rats, Inbred Strains; Reactive Oxygen Species; Receptors, Leptin; RNA Interference; TRPC6 Cation Channel	2019
Telmisartan inhibits AGE-induced podocyte damage and detachment. Microvascular research, 2013, Volume: 88 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Cell Adhesion; Diabetic Nephropathies; Disease Models, Animal; DNA Damage; Glycation End Products, Advanced; L-Lactate Dehydrogenase; Mice; Podocytes; Telmisartan	2013
The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro. PloS one, 2013, Volume: 8, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endorphins; Epithelial Cells; Glucagon; Glutathione Peroxidase; Hydrogen Peroxide; Insulin; Isoenzymes; Kidney; Losartan; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Superoxide Dismutase	2013
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. The American journal of pathology, 2013, Volume: 183, Issue:1 Topics: Aged; Angiotensin II; Animals; Case-Control Studies; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Down-Regulation; Female; Humans; Immunohistochemistry; Kidney; Linear Models; Male; Membrane Proteins; Microscopy, Electron, Transmission; Middle Aged; Rats; Rats, Sprague-Dawley; Rats, Zucker; Real-Time Polymerase Chain Reaction; Receptor, Notch1; Snail Family Transcription Factors; Transcription Factors	2013
Effect of catalpol on diabetic nephropathy in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Aug-15, Volume: 20, Issue:11 Topics: Angiotensin II; Animals; Collagen Type IV; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Fibronectins; Iridoid Glucosides; Kidney; Male; Organ Size; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; Rehmannia; RNA, Messenger; Transforming Growth Factor beta1	2013
Regulation of urinary ACE2 in diabetic mice. American journal of physiology. Renal physiology, 2013, Aug-15, Volume: 305, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A	2013
Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats. The British journal of nutrition, 2014, Jan-14, Volume: 111, Issue:1 Topics: Angiotensin II; Animals; Antigens, Plant; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Proteins; Globulins; Glycation End Products, Advanced; Glycine max; Insulin Resistance; Isoflavones; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Phytotherapy; Plant Preparations; Rats; Rats, Inbred SHR; Seed Storage Proteins; Soybean Proteins; Thiobarbituric Acid Reactive Substances; Triglycerides	2014
Of diabetic mice and ACE2: a new biomarker of renal disease? American journal of physiology. Renal physiology, 2013, Oct-01, Volume: 305, Issue:7 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Female; Male; Peptidyl-Dipeptidase A	2013
[Changes of angiotensin converting enzyme 2 in the occurrence and development of diabetic renal injury in rat]. Sheng li xue bao : [Acta physiologica Sinica], 2013, Aug-25, Volume: 65, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley	2013
Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2013, Volume: 24, Issue:5 Topics: Adult; Aged; Angiotensin II; Diabetic Nephropathies; Disease Progression; Endothelin-1; Female; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Male; Middle Aged; Nephritis, Interstitial	2013
Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation. Journal of physiology and biochemistry, 2014, Volume: 70, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycation End Products, Advanced; Kidney; Organ Size; Pyruvaldehyde; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Vascular Endothelial Growth Factor A; Weight Gain	2014
PTGER1 deletion attenuates renal injury in diabetic mouse models. The American journal of pathology, 2013, Volume: 183, Issue:6 Topics: Actins; Angiotensin II; Animals; Bridged Bicyclo Compounds; Caproates; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Deletion; Gene Expression Regulation; Glomerular Filtration Barrier; Mesenteric Arteries; Mice; Mice, Knockout; Receptors, Prostaglandin E, EP1 Subtype; Renin-Angiotensin System; Superoxides; Vasoconstriction	2013
Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis. International journal of medical sciences, 2013, Volume: 10, Issue:12 Topics: Angiotensin II; Cholesterol; Diabetic Nephropathies; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Humans; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Membrane Proteins; Mesangial Cells; ras Proteins; Receptor, Angiotensin, Type 1; Receptors, Lipoprotein; Renin-Angiotensin System; Sterol Regulatory Element Binding Protein 2; Sterol Regulatory Element Binding Proteins	2013
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy. Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:2 Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin	2014
High glucose induces activation of the local renin‑angiotensin system in glomerular endothelial cells. Molecular medicine reports, 2014, Volume: 9, Issue:2 Topics: Angiotensin II; Angiotensinogen; Animals; Cells, Cultured; Diabetic Nephropathies; Endothelial Cells; Glucose; Humans; Kidney; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; RNA, Messenger	2014
Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. The American journal of pathology, 2014, Volume: 184, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Podocytes; Rats; Rats, Wistar; Renin-Angiotensin System; TRPC Cation Channels; TRPC6 Cation Channel	2014
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade. Kidney international, 2015, Volume: 87, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A	2015
[Protective effects and mechanism of congguiyishen capsules on diabetic nephropathy rats]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2014, Volume: 37, Issue:5 Topics: Angiotensin II; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Female; Hypoglycemic Agents; Kidney; Male; Plants, Medicinal; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin	2014
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy. Proceedings of the National Academy of Sciences of the United States of America, 2014, Dec-16, Volume: 111, Issue:50 Topics: Analysis of Variance; Angiotensin II; Animals; Arachidonic Acids; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression Regulation; Losartan; Models, Biological; Podocytes; Pyrazoles; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Cannabinoid, CB1; RNA Interference; RNA, Small Interfering; Sulfonamides	2014
Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats. European journal of pharmacology, 2015, Mar-05, Volume: 750 Topics: Acrylates; Angiotensin II; Animals; Blood Glucose; Catalase; Cholesterol; Collagen Type IV; Diabetic Nephropathies; Diet, High-Fat; Gene Expression Regulation, Enzymologic; Glutathione; Imidazoles; Kidney; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Thiophenes; Transforming Growth Factor beta1; Triglycerides	2015
Cross-talk between angiotensin-II and toll-like receptor 4 triggers a synergetic inflammatory response in rat mesangial cells under high glucose conditions. Biochemical and biophysical research communications, 2015, Apr-03, Volume: 459, Issue:2 Topics: Angiotensin II; Animals; Cell Line; Chemokine CCL2; Diabetic Nephropathies; Glucose; Inflammation Mediators; Interleukin-6; Mesangial Cells; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Renin-Angiotensin System; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 4; Up-Regulation	2015
Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease. Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:12 Topics: Albuminuria; Angiotensin II; Animals; Cell Dedifferentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Knockout Techniques; Glomerular Basement Membrane; Glucose; Humans; LIM-Homeodomain Proteins; Male; Mice; Muscle Proteins; Podocytes; Protein Transport; Transcription Factors; Transforming Growth Factor beta1; Wnt Signaling Pathway	2015
Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy. Journal of molecular medicine (Berlin, Germany), 2016, Volume: 94, Issue:2 Topics: Angiotensin II; Animals; Biomarkers; Blood Chemical Analysis; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibrosis; Kidney Function Tests; Male; Peptide Fragments; Podocytes; Rats; Receptor, Angiotensin, Type 1; Renin; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta1; Vaccines	2016
Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels. Scientific reports, 2015, Dec-10, Volume: 5 Topics: Albuminuria; Angiotensin II; Animals; Calcium; Diabetic Nephropathies; Disease Models, Animal; Gene Expression; Podocytes; Rats; Rats, Inbred Dahl; TRPC Cation Channels	2015
Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. Journal of nephrology, 2016, Volume: 29, Issue:6 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arachidonate 12-Lipoxygenase; Cadherins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Kidney Glomerulus; Lipoxygenase Inhibitors; Losartan; Male; Membrane Proteins; Mice; Podocytes; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Streptozocin	2016
The Expression Profile of Complement Components in Podocytes. International journal of molecular sciences, 2016, Mar-30, Volume: 17, Issue:4 Topics: Angiotensin II; Animals; Carrier Proteins; Cells, Cultured; Complement System Proteins; Diabetic Nephropathies; Disease Models, Animal; Humans; Interleukin-6; Male; Microfilament Proteins; Microscopy, Confocal; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Transcriptome; Transforming Growth Factor beta	2016
Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model. Molecular medicine reports, 2016, Volume: 14, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Diabetic Nephropathies; Disease Models, Animal; In Vitro Techniques; Janus Kinases; Melatonin; Membrane Potential, Mitochondrial; Mice; Mitochondria; Oxidative Stress; Podocytes; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; STAT Transcription Factors	2016
Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis. Kidney & blood pressure research, 2016, Volume: 41, Issue:6 Topics: Albuminuria; Angiotensin II; Animals; Apoptosis; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Imidazoles; Male; Mice; Mice, Inbred Strains; p38 Mitogen-Activated Protein Kinases; Podocytes; Sirtuin 1; Tetrazoles	2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy. Kidney international, 2017, Volume: 91, Issue:6 Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoantigens; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Time Factors	2017
Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Immunohistochemistry; Irbesartan; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2008
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. Journal of hypertension, 2008, Volume: 26, Issue:9 Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension, Renal; Kidney Cortex; Male; Podocytes; Rats; Rats, Inbred OLETF; RNA, Messenger; Telmisartan	2008
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2008, Volume: 40, Issue:11 Topics: Angiotensin II; Cell Nucleus; Cells, Cultured; Diabetic Nephropathies; Epithelial Cells; Gene Expression; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; NF-kappa B; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones; Tyrosine	2008
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:5 Topics: Acrylamides; Adipocytes, White; Angiotensin II; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Collagen Type I; Cytokines; Diabetic Nephropathies; Gene Expression; Glucose; Glucose Transporter Type 1; Mesangial Cells; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Phosphorylation; Piperidines; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transforming Growth Factor beta1	2008
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:5 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Kidney; Male; Microdialysis; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan	2008
Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy? The Journal of physiology, 2008, Nov-15, Volume: 586, Issue:22 Topics: Angiotensin II; Animals; Binding Sites; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Phosphorylation; Protein Subunits; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Sodium-Potassium-Exchanging ATPase	2008
Role of kidney ADP-ribosyl cyclase in diabetic nephropathy. American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:2 Topics: ADP-ribosyl Cyclase; Albuminuria; Angiotensin II; Animals; Azo Compounds; Cell Nucleus; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Phosphorylation; Proto-Oncogene Proteins c-akt	2009
Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:2 Topics: Abietanes; Angiotensin II; Animals; Blood Glucose; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Macrophages; Monocytes; Neutrophil Infiltration; Phenanthrenes; Protective Agents; Proteinuria; Rats; Transforming Growth Factor beta1	2009
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:3 Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ergocalciferols; Fibrosis; Glomerular Basement Membrane; Inflammation Mediators; Losartan; Macrophages; Mice; Mice, Inbred DBA; Podocytes; Renin; Renin-Angiotensin System; Time Factors; Vitamins	2009
Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression. Molecular and cellular endocrinology, 2010, Feb-05, Volume: 315, Issue:1-2 Topics: Angiotensin II; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Humans; Kidney; Male; Mesangial Cells; Prorenin Receptor; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Renin; RNA, Messenger	2010
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Cell Proliferation; Cells, Cultured; Diabetic Nephropathies; Down-Regulation; Humans; Membrane Proteins; Podocytes; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Rosiglitazone; Stress, Mechanical; Thiazolidinediones; Up-Regulation	2010
Chymase: the other ACE? American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:1 Topics: Angiotensin II; Animals; Chymases; Diabetes Complications; Diabetic Nephropathies; Disease Models, Animal; Humans; Hypertension; Kidney; Mice; Peptidyl-Dipeptidase A; Receptors, Leptin; Signal Transduction	2010
Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes, 2010, Volume: 59, Issue:2 Topics: Actins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Coagulation; Blood Glucose; Blood Pressure; Collagen; Diabetic Nephropathies; Disease Progression; Heparin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Peptidyl-Dipeptidase A; Recombinant Proteins; RNA, Messenger	2010
Critical role for osteopontin in diabetic nephropathy. Kidney international, 2010, Volume: 77, Issue:7 Topics: Albuminuria; Angiotensin II; Animals; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Hypoglycemic Agents; Insulin; Kidney Glomerulus; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR gamma; Thiazolidinediones; Transforming Growth Factor beta	2010
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrons; Peptidyl-Dipeptidase A; Phenotype; Receptor, Angiotensin, Type 1; Tetrazoles	2010
Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:8 Topics: Angiotensin II; Animals; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetic Nephropathies; Disease Models, Animal; Glucose; Hypertrophy; Mice; Parathyroid Hormone-Related Protein; Peptide Fragments; Podocytes; Signal Transduction; Transforming Growth Factor beta1	2010
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7 Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents	2010
[Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2010, Volume: 30, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetic Nephropathies; Drugs, Chinese Herbal; Kidney; Male; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger	2010
Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension. American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Homeostasis; Hypertension; Kidney; Male; Muscle, Smooth, Vascular; Nephrons; Papaverine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renin; Streptozocin; Vasodilator Agents	2010
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney international, 2010, Volume: 78, Issue:9 Topics: Albuminuria; Angiotensin II; Animals; Antioxidants; Bilirubin; Biliverdine; Blood Glucose; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Endothelial Cells; Glomerular Mesangium; Glucose; Humans; Hyperbilirubinemia, Hereditary; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Gunn; Superoxides; Time Factors; Transforming Growth Factor beta1	2010
Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells. Arzneimittel-Forschung, 2010, Volume: 60, Issue:7 Topics: Aldosterone; Angiotensin II; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP11B2; Diabetic Nephropathies; Glucose; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Mesangial Cells; Pyrroles; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2010
High glucose upregulates upstream stimulatory factor 2 in human renal proximal tubular cells through angiotensin II-dependent activation of CREB. Nephron. Experimental nephrology, 2011, Volume: 117, Issue:3 Topics: Angiotensin II; Cell Line; Cyclic AMP Response Element-Binding Protein; Diabetic Nephropathies; Glucose; Humans; Kidney Tubules, Proximal; Losartan; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Up-Regulation; Upstream Stimulatory Factors	2011
[Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2010, Volume: 33, Issue:4 Topics: Angiotensin II; Animals; Anthraquinones; Cells, Cultured; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Epithelial Cells; Glucose; Hypertrophy; Kidney Tubules, Proximal; Leucine; Proteins; Random Allocation; Rats; Rats, Sprague-Dawley; Rheum	2010
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects? Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:12 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System	2010
Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan. Health policy (Amsterdam, Netherlands), 2011, Volume: 100, Issue:2-3 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Databases as Topic; Diabetic Nephropathies; Disease Progression; Female; Guideline Adherence; Humans; Hypertension; Male; Middle Aged; Practice Patterns, Physicians'; Proteinuria; Taiwan; Vasoconstrictor Agents	2011
Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Endocrine research, 2011, Volume: 36, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Cell Line; Diabetic Nephropathies; Glomerular Mesangium; Nicotinamide Phosphoribosyltransferase; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger	2011
Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. American journal of physiology. Renal physiology, 2011, Volume: 300, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Body Weight; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Immunohistochemistry; Mesangial Cells; Mice; NADPH Oxidases; Peptide Fragments; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric	2011
Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. Free radical research, 2011, Volume: 45, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Benzoates; Collagen Type III; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Mice; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Telmisartan; Transforming Growth Factor beta1; Up-Regulation	2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy. Diabetes, 2011, Volume: 60, Issue:6 Topics: Actins; Angiotensin II; Apoptosis; Blotting, Western; Cadherins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Diabetic Nephropathies; Fibronectins; Humans; Intermediate Filament Proteins; Membrane Proteins; Nerve Tissue Proteins; Nestin; Podocytes; Transforming Growth Factor beta; Vimentin	2011
Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:2 Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Blood Glucose; Cell Shape; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Glucose; Humans; Male; Mesangial Cells; NADPH Oxidase 4; NADPH Oxidases; Oxidants; Oxidative Stress; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Fusion Proteins; RNA Interference; Signal Transduction; Time Factors; TRPC Cation Channels; TRPC6 Cation Channel	2011
Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction. American journal of nephrology, 2011, Volume: 34, Issue:4 Topics: Albuminuria; Angiotensin II; Animals; Apoptosis; Blood Pressure; Crosses, Genetic; Diabetic Nephropathies; Immunohistochemistry; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Podocytes; Receptor for Advanced Glycation End Products; Receptors, Angiotensin; Receptors, Immunologic	2011
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:1 Topics: Adaptation, Physiological; Adolescent; Adult; Aged; Angiotensin II; Animals; Apoptosis; Caspases; Cells, Cultured; Child; Child, Preschool; Diabetic Nephropathies; Glucose; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Middle Aged; Molecular Chaperones; Podocytes; Rats; Rats, Inbred WKY	2012
Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A. Microvascular research, 2012, Volume: 84, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cyclic AMP-Dependent Protein Kinases; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide 1; Hormones; Humans; Intercellular Adhesion Molecule-1; Isoquinolines; Mesangial Cells; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Sulfonamides; Up-Regulation	2012
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes. Diabetes, 2012, Volume: 61, Issue:11 Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium; Exenatide; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-raf; Receptors, Glucagon; RNA Interference; Signal Transduction; Tissue Culture Techniques; Venoms	2012
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. American journal of physiology. Renal physiology, 2013, Mar-01, Volume: 304, Issue:5 Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney; Male; Rats; Receptor, Adenosine A1; Renal Circulation; Tetrazoles; Vascular Resistance; Xanthines	2013
Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes. Chinese medical journal, 2002, Volume: 115, Issue:7 Topics: Amlodipine; Angiotensin II; Animals; Bosentan; Calcium Channel Blockers; Collagen Type IV; Diabetic Nephropathies; Drug Therapy, Combination; Endothelin Receptor Antagonists; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Diabetic nephropathy. The New England journal of medicine, 2002, Sep-19, Volume: 347, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension	2002
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. American journal of physiology. Renal physiology, 2002, Volume: 283, Issue:5 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cell Division; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Diabetic Nephropathies; Extracellular Matrix Proteins; Fibronectins; Gene Expression Regulation, Enzymologic; Glomerular Mesangium; Hypertrophy; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; RNA, Messenger; Vasoconstrictor Agents	2002
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes, 2003, Volume: 52, Issue:4 Topics: Adult; Aged; Albuminuria; Angiotensin II; Biopsy; Blotting, Western; Cells, Cultured; Cytochalasin B; Cytoskeleton; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluorescent Antibody Technique, Indirect; Gene Expression; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Kidney; Male; Membrane Proteins; Microscopy, Fluorescence; Middle Aged; Nephrotic Syndrome; Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Tissue Distribution	2003
Summaries for patients. Effects of blood pressure drugs in patients with diabetes and kidney disease. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
[Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!]. MMW Fortschritte der Medizin, 2003, Mar-06, Volume: 145, Issue:10 Topics: Adolescent; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Kidney Failure, Chronic; Risk Factors; Smoking Cessation; Sodium Chloride Symporter Inhibitors; Time Factors	2003
Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:7 Topics: Adult; Aged; Angiotensin II; Cells, Cultured; Chymases; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Humans; Hypertension; Immunohistochemistry; Kidney; Kidney Tubules; Leukocytes, Mononuclear; Middle Aged; Myocytes, Smooth Muscle; Peptidyl-Dipeptidase A; Serine Endopeptidases; Up-Regulation	2003
Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells. American journal of physiology. Renal physiology, 2003, Volume: 285, Issue:6 Topics: Angiotensin II; Animals; Antibodies; Aorta; Calcium; Calcium Channels; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Inositol 1,4,5-Trisphosphate Receptors; Kidney Glomerulus; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Vasoconstriction; Vasoconstrictor Agents	2003
Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:5 Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetic Nephropathies; Endocytosis; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Vasoconstrictor Agents	2003
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk. The American journal of cardiology, 2003, Oct-01, Volume: 92, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Evidence-Based Medicine; Humans; Hypertension; Losartan; Risk Management; Treatment Outcome	2003
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; DNA-Binding Proteins; Enzyme Inhibitors; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney Glomerulus; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrphostins	2004
Inhibition of the renin-angiotensin system: added value in reducing cardiovascular and renal risk? Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renal Insufficiency; Renin-Angiotensin System; Risk Factors	2004
[Microalbuminuria is an early marker for increased morbidity and mortality]. Fortschritte der Medizin. Originalien, 2003, Feb-27, Volume: 121 Suppl 1 Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke	2003
Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene therapy, 2004, Volume: 11, Issue:11 Topics: Angiotensin II; Animals; Base Sequence; Cell Division; Diabetic Nephropathies; Extracellular Matrix; Gene Expression; Genetic Therapy; Glomerular Mesangium; Glucose; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Transfection	2004
[The preliminary studies on the cross action between endothelin-1 and angiotensin II in kidney tissue of rats with diabetic nephropathy]. Zhonghua yi xue za zhi, 2004, Feb-02, Volume: 84, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Endothelin-1; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; RNA, Messenger	2004
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Carboxypeptidases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Induction; Kidney Tubules; Lipids; Lung; Membrane Proteins; Mice; Myocardium; Organ Size; Organ Specificity; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger	2004
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade. Journal of hypertension, 2004, Volume: 22, Issue:8 Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Fluid; Kidney; Losartan; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan	2004
Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:8 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Biomarkers; Chemokine CCL2; Diabetic Nephropathies; Electrophoretic Mobility Shift Assay; Gene Expression; I-kappa B Proteins; Macrophages; Male; NF-kappa B; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thiocarbamates; Transcription Factor RelA	2004
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. The Journal of clinical investigation, 2004, Volume: 114, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Antibodies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Kidney; Peptides; Protein Conformation; Protein Precursors; Protein Structure, Tertiary; Rats; Renin; Renin-Angiotensin System; Urine	2004
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney international, 2005, Volume: 67, Issue:1 Topics: Adult; Aged; Angiotensin II; Base Sequence; Case-Control Studies; Cell Line; Diabetic Nephropathies; DNA; Female; Gene Expression; Glucose; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Proteins; Risk Factors; RNA, Messenger; Solubility; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1	2005
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta	2005
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney international, 2005, Volume: 67, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Imidazoles; Kidney; Kidney Glomerulus; Male; Mice; Rats; Streptozocin; Tetrazoles; Tumor Suppressor Proteins	2005
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. American journal of physiology. Renal physiology, 2005, Volume: 288, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Glomerulus; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley	2005
Effect of high glucose on superoxide in human mesangial cells: role of angiotensin II. Nephron. Experimental nephrology, 2005, Volume: 100, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cell Culture Techniques; Diabetic Nephropathies; Glucose; Humans; Irbesartan; Kidney Glomerulus; Losartan; Oxidants; Superoxide Dismutase; Superoxides; Tetrazoles	2005
Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2005, Volume: 25, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Function Tests; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protective Agents; Random Allocation; Rats; Rats, Wistar	2005
Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy. The Japanese journal of veterinary research, 2005, Volume: 53, Issue:1-2 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Insulin; Kidney; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred MRL lpr; Organ Size; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Up-Regulation	2005
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:1 Topics: Angiotensin II; Animals; Anticholesteremic Agents; Blood Glucose; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Janus Kinase 2; Male; Mesangial Cells; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; rho GTP-Binding Proteins; Signal Transduction; Simvastatin; STAT1 Transcription Factor; STAT3 Transcription Factor; Terpenes	2006
Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats. Experimental animals, 2006, Volume: 55, Issue:1 Topics: Angiotensin II; Animals; Cyclooxygenase 2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Kidney; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Long-Evans; Renin	2006
Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Kidney international, 2006, Volume: 69, Issue:6 Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Gene Expression Profiling; Glucose; Glycoproteins; Kidney Tubules, Proximal; Male; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Inbred BB; Rats, Wistar; Reactive Oxygen Species; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2006
The CARI guidelines. Prevention of progression of kidney disease. Nephrology (Carlton, Vic.), 2006, Volume: 11 Suppl 1 Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy	2006
An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:9 Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; Collagen Type IV; Diabetic Nephropathies; Gene Expression; Glucose; Humans; Immunohistochemistry; In Vitro Techniques; Kidney Tubules, Proximal; Male; Matrix Metalloproteinase 2; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes, 2006, Volume: 55, Issue:6 Topics: Adenoviridae; Angiotensin II; Animals; Blood Glucose; Blotting, Western; Body Weight; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Eye Proteins; Fibronectins; Genetic Therapy; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Metalloproteases; Nerve Growth Factors; Proteinuria; Rats; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Smad3 Protein; Streptozocin; Transforming Growth Factor beta1	2006
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazolidines; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinases; Phosphorylation; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin; Renin-Angiotensin System	2006
Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Laboratory investigation; a journal of technical methods and pathology, 2006, Volume: 86, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Butadienes; Cell Line; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Glomerular Mesangium; Imidazoles; Male; Mesangial Cells; Nitriles; Phosphorylation; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Smad1 Protein; src-Family Kinases; Tetrazoles	2006
The parathyroid hormone-related protein system and diabetic nephropathy outcome in streptozotocin-induced diabetes. Kidney international, 2006, Volume: 69, Issue:12 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blotting, Western; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Gene Expression Regulation; Hypertrophy; Immunohistochemistry; Kidney Tubules; Losartan; Mesangial Cells; Mice; Mice, Transgenic; Parathyroid Hormone-Related Protein; Podocytes; Receptor, Parathyroid Hormone, Type 1	2006
ACE inhibitor use and the long-term risk of renal failure in diabetics. Kidney international, 2006, Volume: 70, Issue:7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tretinoin	2006
Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clinical and experimental nephrology, 2007, Volume: 11, Issue:1 Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Transforming Growth Factor beta; Renin-Angiotensin System; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2007
Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Hypoglycemic Agents; Insulin; Kidney; Male; Molecular Weight; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats; Rats, Wistar; Renin-Angiotensin System	2007
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney international, 2007, Volume: 72, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Kidney Glomerulus; Leucine; Mice; Peptidyl-Dipeptidase A; Streptozocin; Up-Regulation	2007
Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 150, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Kidney Function Tests; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Streptozocin; Vascular Resistance; Vasoconstriction; Vasodilation	2007
Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:3 Topics: Amides; Angiotensin II; Animals; Arterioles; C-Peptide; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Norepinephrine; Potassium Chloride; Pyridines; Rho Factor; rho-Associated Kinases; Vasoconstriction; Vasoconstrictor Agents	2008
Activation of a local renin angiotensin system in podocytes by glucose. American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Diabetic Nephropathies; DNA Primers; Glucose; Kidney; Mice; Podocytes; Polymerase Chain Reaction; Renin; Renin-Angiotensin System; RNA, Messenger	2008
Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:3 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Lipid Metabolism; Mesangial Cells; Mice; Mice, Inbred C57BL; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; RNA, Small Interfering; Up-Regulation	2008
The role of SGK-1 in angiotensin II-mediated sodium reabsorption in human proximal tubular cells. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:6 Topics: Analysis of Variance; Angiotensin II; Blotting, Western; Cells, Cultured; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glucose; Humans; Kidney Tubules, Proximal; Probability; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Up-Regulation	2008
PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cellular signalling, 2008, Volume: 20, Issue:5 Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Heterogeneous-Nuclear Ribonucleoprotein K; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Protein Biosynthesis; Protein Kinase C-delta; RNA, Messenger; Serine; Signal Transduction; Vascular Endothelial Growth Factor A	2008
[The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:1 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radioimmunoassay; Renin; Renin-Angiotensin System; Time Factors	2008
The collecting duct is the major source of prorenin in diabetes. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension, Renal; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Microscopy, Fluorescence; Quinacrine; Rats; Rats, Wistar; Renin; Tetrazoles; Trypsin; Vasoconstrictor Agents	2008
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Hypertension, Renal; Kidney; Male; Neuropeptide Y; Peptide Fragments; Pyrazines; Rats; Rats, Inbred SHR; Renal Circulation; Sitagliptin Phosphate; Sympathetic Nervous System; Triazoles; Vasoconstrictor Agents	2008
ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells. Experimental biology and medicine (Maywood, N.J.), 2008, Volume: 233, Issue:8 Topics: Angiotensin II; Captopril; Cells, Cultured; Chymases; Diabetic Nephropathies; Glucose; Humans; Losartan; Mesangial Cells; Oligopeptides; Peptidyl-Dipeptidase A; RNA, Messenger	2008
Renin secretion in advanced diabetic nephropathy. Scandinavian journal of urology and nephrology. Supplementum, 1984, Volume: 79 Topics: Adult; Angiotensin II; Captopril; Chlorides; Diabetic Nephropathies; Dihydralazine; Humans; Hypertension; Middle Aged; Renin	1984
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria. Japanese journal of medicine, 1981, Volume: 20, Issue:3 Topics: Aldosterone; Angiotensin II; Bed Rest; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Humans; Male; Middle Aged; Proteinuria; Renin; Renin-Angiotensin System	1981
Losartan in patients with renal insufficiency. The Canadian journal of cardiology, 1995, Volume: 11 Suppl F Topics: Acute Kidney Injury; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Losartan; Tetrazoles	1995
Abnormality of the glomerular angiotensin II receptor in experimental diabetic nephropathy. Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:5 Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerulonephritis, IGA; Hypertension; Kidney Glomerulus; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin	1993
Dietary myo-inositol restores diabetic renal arteriolar reactivity to angiotensin II but not to norepinephrine. Microcirculation (New York, N.Y. : 1994), 1996, Volume: 3, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Female; Hydronephrosis; Inositol; Kidney; Membrane Lipids; Microcirculation; Norepinephrine; Phospholipids; Rats; Rats, Wistar; Renin; Streptozocin; Vasoconstriction; Vasoconstrictor Agents	1996
Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat. Diabetologia, 1996, Volume: 39, Issue:8 Topics: Aldehyde Reductase; Angiotensin II; Animals; Arterioles; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet; Disease Models, Animal; Enzyme Inhibitors; Galactitol; Galactose; Image Processing, Computer-Assisted; In Vitro Techniques; Kidney; Male; Muscle, Smooth, Vascular; Naphthalenes; Perfusion; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents	1996
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes, 1997, Volume: 46, Issue:1 Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, Sodium-Restricted; Glomerular Filtration Rate; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reference Values; Regression Analysis; Renin; Time Factors	1997
Alteration of cytosolic calcium induced by angiotensin II and norepinephrine in mesangial cells from diabetic rats. Kidney international, 1997, Volume: 51, Issue:1 Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cytosol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucose; Male; Norepinephrine; Rats; Rats, Wistar; Vasoconstrictor Agents	1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy. American journal of hypertension, 1997, Volume: 10, Issue:3 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles	1997
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes, 1997, Volume: 46, Issue:10 Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan	1997
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:5 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains	1997
A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors. Medical hypotheses, 1998, Volume: 50, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Activation; Fish Oils; Heparitin Sulfate; Humans; Hyperglycemia; Kidney Glomerulus; Lipid Peroxidation; Models, Biological; Nitric Oxide; Protein Kinase C; Thromboxane A2; Transforming Growth Factor beta	1998
Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:1 Topics: Acrylates; Adult; Angiotensin II; Diabetic Nephropathies; Glomerular Filtration Rate; Hemodynamics; Humans; Hyperglycemia; Imidazoles; Kidney; Male; Middle Aged; Renal Circulation; Renin; Renin-Angiotensin System; Thiophenes	2000
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney international, 2000, Volume: 58, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Hypertrophy; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger	2000
Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy. Nephron, 2000, Volume: 86, Issue:4 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Proteinuria	2000
Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy. Endocrine journal, 2001, Volume: 48, Issue:1 Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin	2001
[Inhibition of the renin-angiotensin system in type 2 diabetes. New significant results concerning type 2 diabetes and renal disease]. Ugeskrift for laeger, 2001, Oct-01, Volume: 163, Issue:40 Topics: Angiotensin II; Antihypertensive Agents; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Renin-Angiotensin System	2001
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. The Medical journal of Australia, 2001, Oct-15, Volume: 175, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Irbesartan; Kidney; Losartan; Male; Primary Prevention; Prognosis; Tetrazoles; Treatment Outcome	2001
Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. Kidney international, 2002, Volume: 61, Issue:1 Topics: Angiotensin II; Animals; Cell Count; Cell Division; Cells, Cultured; Cholesterol, LDL; Collagen Type I; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA; Extracellular Matrix; Gene Expression; Glomerular Mesangium; Iodine Radioisotopes; Lipoproteins, LDL; Male; Matrix Metalloproteinase 2; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred OLETF; Receptors, LDL; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents	2002
[Angiotensin II receptor antagonists reduce the development of nephropathies in type 2 diabetes. Three new studies are of interest, but don't answer all questions]. Lakartidningen, 2001, Nov-07, Volume: 98, Issue:45 Topics: Angiotensin II; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Follow-Up Studies; Humans; Losartan; Randomized Controlled Trials as Topic	2001
[Angiotensin 2 receptor blockaders: how do we explain the kidney-protective effect?]. Lakartidningen, 2002, Jan-10, Volume: 99, Issue:1-2 Topics: Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles	2002
[Diabetic patient with hypertension takes A-I I blocker. Less likely dialysis]. MMW Fortschritte der Medizin, 2002, Feb-21, Volume: 144, Issue:8 Topics: Albuminuria; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Diabetes Complications; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Risk Factors; Tetrazoles	2002
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney international, 2002, Volume: 61, Issue:5 Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; Collagen Type IV; Diabetic Nephropathies; DNA-Binding Proteins; Glomerular Mesangium; Glucose; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Vasoconstrictor Agents	2002
Renin-angiotensin-aldosterone system in diabetes mellitus. Diabetes, 1976, Volume: 25, Issue:2 SUPPL Topics: Aldosterone; Angiotensin II; Animals; Blood Volume; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Hypertension; Hypotension, Orthostatic; Juxtaglomerular Apparatus; Models, Biological; Potassium; Rats; Renin; Sodium; Vascular Resistance; Water-Electrolyte Balance	1976
[The renin-angiotensin system in diabetes mellitus (author's transl)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1977, Jul-10, Volume: 66, Issue:7 Topics: Adolescent; Adult; Aged; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Renin	1977
[Diabetes mellitus and its complications in Japan. The dysfunction of mesangial cells on pathogenesis of diabetic nephropathy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9 Topics: Angiotensin II; Animals; Collagen; Diabetic Nephropathies; Endothelins; Glomerular Filtration Rate; Glomerular Mesangium; Humans; Regional Blood Flow	1991
Vasoregulatory hormones and the hyperfiltration of diabetes. The American journal of physiology, 1988, Volume: 254, Issue:2 Pt 2 Topics: Algorithms; Angiotensin II; Animals; Aprotinin; Bradykinin; Diabetic Nephropathies; Dinoprostone; Glomerular Filtration Rate; Hemodynamics; Indomethacin; Kidney; Male; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Saralasin	1988
On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scandinavian journal of clinical and laboratory investigation, 1989, Volume: 49, Issue:6 Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Atrial Natriuretic Factor; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Extracellular Space; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Plasma Volume; Renin; Renin-Angiotensin System	1989
The role of angiotensin-II in progressive diabetic glomerulopathy in the rat. Endocrinology, 1989, Volume: 125, Issue:4 Topics: Albuminuria; Angiotensin II; Animals; Body Weight; Diabetic Nephropathies; DNA; Dogs; Enalapril; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; Proteins; Rats; Rats, Inbred Strains; Reference Values	1989
[Studies on hypoaldosteronism associated with diabetes mellitus: response of plasma steroids to angiotensin II or ACTH administration]. Nihon Naibunpi Gakkai zasshi, 1986, Jul-20, Volume: 62, Issue:7 Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Corticosterone; Desoxycorticosterone; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Female; Humans; Hydrocortisone; Male; Middle Aged; Renin-Angiotensin System	1986
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British medical journal (Clinical research ed.), 1986, Oct-18, Volume: 293, Issue:6553 Topics: Angiotensin II; Diabetic Nephropathies; Humans; Kidney	1986
Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1987, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epinephrine; Female; Humans; Hypertension; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Sodium; Sodium, Dietary; Water-Electrolyte Balance	1987
Elevated blood pressure and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy. Transactions of the American Clinical and Climatological Association, 1986, Volume: 97 Topics: Angiotensin II; Blood Glucose; Blood Pressure; Diabetic Nephropathies; Follow-Up Studies; Humans; Hypertension; Kidney; Longitudinal Studies; Renin-Angiotensin System	1986
[Diagnostic significance of the angiotensin infusion test]. Revista medica de Chile, 1968, Volume: 96, Issue:10 Topics: Adolescent; Adult; Aged; Angiotensin II; Child; Diabetic Nephropathies; Female; Glomerulonephritis; Heart Diseases; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Infusions, Parenteral; Liver Cirrhosis; Male; Metaraminol; Middle Aged; Nephritis	1968